Accolade Acquires MD Insider to Launch Data-Driven Physician Performance Platform

On August 5, 2019, VCBeat (WeChat ID: vcbeat) learned from foreign media reports that healthcare company Accolade announced the acquisition of medical technology company MD Insider. No financial terms of the acquisition were disclosed.

MD Insider, founded in 2012 and headquartered in California, USA, is a medical technology company. The company boasts a professional team of data scientists, software engineers, and healthcare experts, and primarily builds a healthcare data platform through machine learning to serve millions of users.

It is reported that MD Insider has completed five rounds of financing, raising a total of $24.3 million. Specifically, the company closed its $9.5 million Series A round in April 2015 and its $12 million Series B round in December 2015.

MD Insider’s platform primarily aggregates physician data from thousands of healthcare institutions and millions of doctor-patient interaction cases, leveraging data analytics to objectively evaluate physician performance. The platform assesses physicians’ clinical experience and treatment proficiency, recommending more suitable clinicians to patients.

Nowadays, patients are increasingly demanding greater transparency in healthcare. A physician’s clinical competence significantly impacts medical costs, the quality of clinical care, and patient experience. MD Insider believes that authentic and reliable physician data should be provided to the healthcare industry. However, information offered by current physician review websites is often vague, leading to patient confusion and even misjudgment of physicians’ capabilities. MD Insider is committed to addressing these issues and enhancing transparency in the healthcare sector.

“Patients often seek more trustworthy physicians for their care, and healthcare organizations need methods to evaluate physician performance to ensure better clinical outcomes. To align with the trend toward transparency in physician performance, we require more mature data-driven review mechanisms,” said Dr. Etai Adam, an oncologist at Children’s Hospital Los Angeles in the United States.

Accolade, founded in 2007 and headquartered in Pennsylvania, USA, is a rapidly growing healthcare company. The company primarily provides personalized healthcare services to its clients, such as health plan development and medical consultation. Accolade’s team possesses expertise in healthcare, consumer services, software technology, and data science, and is committed to helping users reduce healthcare costs and improve their healthcare experience. Due to its high user satisfaction, Accolade was named by Forbes as one of the 25 most promising companies in the United States.

Through the acquisition of MD Insider, Accolade launched the Accolade Total Care program. This initiative combines data-driven physician performance evaluation with healthcare cost transparency, ensuring that users achieve optimal treatment outcomes while reducing medical expenses. Furthermore, Accolade Total Care incentivizes healthcare institutions to deliver higher-quality care to patients.

Furthermore, Accolade will continue to develop MD Insider’s intelligent data platform to analyze patient care pathways, including diagnosis, prognosis, surgical risk rates, potential complications, likelihood of recurrence, and length of hospital stay.

Eric Wilson, CEO of MD Insider, stated, “Physician performance is critical to the quality, outcomes, and cost of healthcare. We are delighted to join the Accolade team to deliver healthcare services to millions of users.”

(Compiled by Xu Xiaoxue)